Johnson & Johnson cleared in baby powder-cancer litigation case in US

By: |
December 22, 2019 6:11 PM

The jury carefully considered the decades of independent clinical evidence, which show Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer.

India is a major market for J&J globally, and its share in the country’s Rs 4,000-crore baby care market is nearly three-fourths.

The baby powder of Johnson & Johnson is not responsible for a Missouri woman’s cancer, a jury in the US has decided in the company’s latest win in a litigation case over its famous product.

The litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson, finding Johnson’s baby powder was not the cause of the Vickie Forrest’s disease.

“This is the fourth consecutive verdict in favour of Johnson & Johnson in these cases and the eighth defense verdict this year,” a Johnson & Johnson company spokesperson said in a statement.

The jury carefully considered the decades of independent clinical evidence, which show Johnson’s Baby Powder is safe, does not contain asbestos, and does not cause cancer, it added.

“We know that anyone suffering from cancer is searching for answers, which is why the science and facts on this topic are so important,” the statement said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Mukesh Ambani’s RIL slips 59 places on Fortune list, SBI jumps 16 notches
2Forging industry seeks PMO’s intervention over high steel prices
3National SC-ST Hub: 50% jump in funds released for SC-ST entrepreneurs to boost entrepreneurship in FY21